BRPI1015363A2 - Compostos de quinazolina contendo fósforo, uso dos mesmos, composição e kit - Google Patents
Compostos de quinazolina contendo fósforo, uso dos mesmos, composição e kitInfo
- Publication number
- BRPI1015363A2 BRPI1015363A2 BRPI1015363-2A BRPI1015363A BRPI1015363A2 BR PI1015363 A2 BRPI1015363 A2 BR PI1015363A2 BR PI1015363 A BRPI1015363 A BR PI1015363A BR PI1015363 A2 BRPI1015363 A2 BR PI1015363A2
- Authority
- BR
- Brazil
- Prior art keywords
- kit
- composition
- compounds containing
- containing phosphorus
- quinazoline compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
- C07F9/65685—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine oxide or thioxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65128—Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22255109P | 2009-07-02 | 2009-07-02 | |
| PCT/US2010/001897 WO2011002523A1 (en) | 2009-07-02 | 2010-07-02 | Phosphorus containing quinazoline compounds and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1015363A2 true BRPI1015363A2 (pt) | 2015-08-25 |
Family
ID=43411348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1015363-2A BRPI1015363A2 (pt) | 2009-07-02 | 2010-07-02 | Compostos de quinazolina contendo fósforo, uso dos mesmos, composição e kit |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8987284B2 (pt) |
| EP (1) | EP2448409A4 (pt) |
| JP (1) | JP5721709B2 (pt) |
| KR (1) | KR20120090025A (pt) |
| CN (1) | CN102711472B (pt) |
| AU (1) | AU2010266725A1 (pt) |
| BR (1) | BRPI1015363A2 (pt) |
| CA (1) | CA2804190A1 (pt) |
| HK (1) | HK1176519A1 (pt) |
| IL (1) | IL217222A0 (pt) |
| MX (1) | MX2012000166A (pt) |
| RU (1) | RU2012103492A (pt) |
| SG (1) | SG177451A1 (pt) |
| WO (1) | WO2011002523A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011002523A1 (en) | 2009-07-02 | 2011-01-06 | Kanionusa Inc. | Phosphorus containing quinazoline compounds and methods of use |
| US8916574B2 (en) | 2009-09-28 | 2014-12-23 | Qilu Pharmaceutical Co., Ltd. | 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors |
| JP5960253B2 (ja) | 2011-05-31 | 2016-08-02 | ニューゲン セラピューティクス， インコーポレイテッド | ポリ（ａｄｐ−リボース）ポリメラーゼの三環系阻害剤 |
| CN103772411B (zh) * | 2013-04-28 | 2016-08-03 | 复旦大学 | 含硫6-呋喃基喹唑啉-4-胺化合物及其制备方法和用途 |
| CN104558042B (zh) * | 2015-01-30 | 2017-03-29 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用 |
| CN104558043B (zh) * | 2015-01-30 | 2017-01-11 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用 |
| CN104558041B (zh) * | 2015-01-30 | 2017-01-11 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用 |
| CN104558040B (zh) * | 2015-01-30 | 2017-04-05 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的晶型及其制备方法和应用 |
| CN104610364B (zh) * | 2015-01-30 | 2017-03-29 | 江苏康缘药业股份有限公司 | 含磷取代的喹唑啉衍生物的新晶型及其制备方法和应用 |
| CN105424831B (zh) * | 2015-11-11 | 2017-11-10 | 江苏康缘药业股份有限公司 | 二对甲苯磺酸缘生替尼原料药中有效成分的定量检测方法 |
| CN105237573B (zh) * | 2015-11-11 | 2017-10-24 | 江苏康缘药业股份有限公司 | 二对甲苯磺酸缘生替尼的制备方法 |
| CN105388242A (zh) * | 2015-11-11 | 2016-03-09 | 江苏康缘药业股份有限公司 | 二对甲苯磺酸缘生替尼原料药中残留溶剂的检测方法 |
| CN105606717B (zh) * | 2015-11-11 | 2017-10-24 | 江苏康缘药业股份有限公司 | 二对甲苯磺酸缘生替尼原料药中有关物质的检测方法 |
| CN108285421A (zh) * | 2018-01-26 | 2018-07-17 | 黑龙江鑫创生物科技开发有限公司 | 一种微通道反应器合成拉帕替尼中间体的方法 |
| CN113995728B (zh) * | 2020-07-28 | 2023-03-14 | 江苏康缘药业股份有限公司 | 一种药物组合物及制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391874B1 (en) | 1996-07-13 | 2002-05-21 | Smithkline Beecham Corporation | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| ID29800A (id) | 1999-02-27 | 2001-10-11 | Boehringer Ingelheim Pharma | Turunan-turunan 4-amino-kinazolin dan kinolin yang mempunyai efek inhibitor pada transduksi signal yang dimediasi oleh tirosin kinase |
| DE19911509A1 (de) | 1999-03-15 | 2000-09-21 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| ES2295035T3 (es) | 1999-07-09 | 2008-04-16 | Glaxo Group Limited | Anilinoquinazolinas como inhibidores de proteina tirosina quinasa. |
| US6894057B2 (en) * | 2002-03-08 | 2005-05-17 | Warner-Lambert Company | Oxo-azabicyclic compounds |
| DE10217689A1 (de) * | 2002-04-19 | 2003-11-13 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
| TWI332956B (en) | 2002-04-26 | 2010-11-11 | Gilead Sciences Inc | Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds |
| NZ540092A (en) | 2002-11-20 | 2007-06-29 | Array Biopharma Inc | Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
| US7223749B2 (en) | 2003-02-20 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| DE10307165A1 (de) | 2003-02-20 | 2004-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung |
| DE10349113A1 (de) * | 2003-10-17 | 2005-05-12 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Aminocrotonylverbindungen |
| JP2007510667A (ja) | 2003-11-07 | 2007-04-26 | スミスクライン ビーチャム （コーク） リミテッド | 癌の治療法 |
| JP2007532658A (ja) | 2004-04-16 | 2007-11-15 | スミスクライン ビーチャム コーポレーション | がんの治療方法 |
| CN101421269A (zh) | 2006-01-13 | 2009-04-29 | 环状药物公司 | 酪氨酸激酶抑制剂及其用途 |
| EP1981863B1 (en) * | 2006-01-26 | 2012-10-10 | Boehringer Ingelheim International GmbH | Process for preparing aminocrotonylamino-substituted quinazoline derivatives |
| US20080234267A1 (en) * | 2007-03-20 | 2008-09-25 | Karen Elizabeth Lackey | Compounds and Methods of Treatment |
| WO2011002523A1 (en) | 2009-07-02 | 2011-01-06 | Kanionusa Inc. | Phosphorus containing quinazoline compounds and methods of use |
-
2010
- 2010-07-02 WO PCT/US2010/001897 patent/WO2011002523A1/en active Application Filing
- 2010-07-02 BR BRPI1015363-2A patent/BRPI1015363A2/pt not_active IP Right Cessation
- 2010-07-02 US US13/380,808 patent/US8987284B2/en active Active
- 2010-07-02 CA CA2804190A patent/CA2804190A1/en not_active Abandoned
- 2010-07-02 KR KR1020127002859A patent/KR20120090025A/ko not_active Application Discontinuation
- 2010-07-02 MX MX2012000166A patent/MX2012000166A/es not_active Application Discontinuation
- 2010-07-02 CN CN201080039138.2A patent/CN102711472B/zh active Active
- 2010-07-02 RU RU2012103492/04A patent/RU2012103492A/ru not_active Application Discontinuation
- 2010-07-02 AU AU2010266725A patent/AU2010266725A1/en not_active Abandoned
- 2010-07-02 JP JP2012517506A patent/JP5721709B2/ja active Active
- 2010-07-02 SG SG2011097581A patent/SG177451A1/en unknown
- 2010-07-02 EP EP10794499.3A patent/EP2448409A4/en not_active Withdrawn
-
2011
- 2011-12-27 IL IL217222A patent/IL217222A0/en unknown
-
2013
- 2013-03-28 HK HK13103910.6A patent/HK1176519A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1176519A1 (zh) | 2013-08-02 |
| US8987284B2 (en) | 2015-03-24 |
| JP5721709B2 (ja) | 2015-05-20 |
| CN102711472A (zh) | 2012-10-03 |
| EP2448409A4 (en) | 2013-04-10 |
| WO2011002523A1 (en) | 2011-01-06 |
| MX2012000166A (es) | 2012-04-02 |
| US20120196833A1 (en) | 2012-08-02 |
| SG177451A1 (en) | 2012-02-28 |
| CA2804190A1 (en) | 2011-01-06 |
| EP2448409A1 (en) | 2012-05-09 |
| IL217222A0 (en) | 2012-02-29 |
| JP2012532100A (ja) | 2012-12-13 |
| CN102711472B (zh) | 2015-12-02 |
| KR20120090025A (ko) | 2012-08-16 |
| RU2012103492A (ru) | 2013-08-10 |
| AU2010266725A1 (en) | 2012-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1015363A2 (pt) | Compostos de quinazolina contendo fósforo, uso dos mesmos, composição e kit | |
| BRPI0815979A2 (pt) | compostos e composições com inibidores de quinase, bem como uso dos mesmos | |
| BRPI0907453A2 (pt) | Compostos, uso e preparação dos mesmos | |
| BRPI1012533A2 (pt) | composto de piradazinona e uso do mesmo | |
| BRPI0813627A2 (pt) | Peptídio antimicrobiano, composições e métodos de uso | |
| BRPI0913086A2 (pt) | Composições antimicrobianas e métodos de uso | |
| BRPI0911688A2 (pt) | "compostos de pirimidina, composições e métodos de uso" | |
| BR112012002331A2 (pt) | composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica | |
| BR112012002349A2 (pt) | composto,e, uso do mesmo | |
| BRPI0911563A2 (pt) | uso de antagonista da progesterona | |
| BRPI0912717A2 (pt) | Composição farmacêutica, e, uso de 5-azacitidina | |
| BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
| BRPI0906973A2 (pt) | Compostos e composições como inibidores de cinase. | |
| BRPI0811635A2 (pt) | Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos | |
| BRPI0907365A2 (pt) | Composição antimicrobiana e uso | |
| BR112013006016A2 (pt) | compostos de azabenzotiazol, composições e métodos de uso | |
| BRPI0819299A2 (pt) | Uso de composição, e, composição contendo proteína | |
| BRPI1007494A2 (pt) | composto e uso do mesmo | |
| BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos | |
| BRPI0813457A2 (pt) | Composto de organoenxofre contendo halogênio e uso do mesmo | |
| SMT201500218B (it) | Composti aril-fenil-solfonammido-cicloalchile e loro uso | |
| CL2007002377A1 (es) | Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno. | |
| BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
| BRPI0913424A2 (pt) | composições agrícolas de baixa taxa de uso e métodos para o uso | |
| BRPI0905715A2 (pt) | Composição farmacêutica e kit de componentes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |